Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Locally Advanced Cutaneous Melanoma: early-phase trial registry

1 of 1 indexed Locally Advanced Cutaneous Melanoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Locally Advanced Cutaneous Melanoma: 1 US clinical trial tracked, 1 recruiting.

Locally Advanced Cutaneous Melanoma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Fred Hutchinson Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition locally-advanced-cutaneous-melanoma

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Locally Advanced Cutaneo (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Locally Advanced Cutaneous Melanoma

Locally Advanced Cutaneous Melanoma lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Locally Advanced Cutaneous Melanoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Locally Advanced Cutaneous Melanoma is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Locally Advanced Cutaneous Melanoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Neoantigen Peptide Vaccine Biological
1 trials
Multigated Acquisition Scan Procedure
1 trials
Poly ICLC Drug
1 trials
Echocardiography Procedure
1 trials
Nivolumab Biological
1 trials

US sites by state

Facility locations filed on Locally Advanced Cutaneous Melanoma trials. A trial with sites in several states counts in each.

Washington 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Locally Advanced Cutaneous Melanoma page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Locally Advanced Cutaneous Melanoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Fred Hutchinson Cancer Center sponsors the most Locally Advanced Cutaneous Melanoma trials on record, review their full trial history before evaluating a specific study. See Fred Hutchinson Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Locally Advanced Cutaneous Melanoma condition card totals 1 registered trials; most-linked intervention Neoantigen Peptide Vaccine; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.